Rogado, Jacobo <br/><br/>
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.  [electronic resource] 

 -  Oncoimmunology  2020 
 - 1751548 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2162-4011 
<br/><br/><label>Standard No.: </label>10.1080/2162402X.2020.1751548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Female<br/>Humans<br/>Immune Checkpoint Inhibitors--administration & dosage<br/>Immunotherapy<br/>Male<br/>Neoplasms--drug therapy<br/>Overweight--immunology<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Retrospective Studies